Ferdinand Haller

Ferdinand Haller is a Senior Scientist at Formycon AG, responsible for the analytical development of a biosimilar program and acting as the primary contact for analytical topics. Prior experience includes roles as Lead Project Analyst at Novartis, overseeing analytical tasks for multiple biosimilar projects, and laboratory head at Sandoz, where responsibilities included managing extraction and leachable studies along with analytical method development. Ferdinand's earlier positions involved managing stability studies for pharmaceutical drug products at Sandoz and supporting biopharmaceutical development projects at flexible4science. Ferdinand holds a Ph.D. in Biochemistry and Molecular Biology from Helmholtz Zentrum München and a Master of Science in Biochemistry from the Technical University of Munich.